Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of fimh
US-2026070939-A1 · Mar 12, 2026 · US
with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07H15/23 |
| Official title | with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin |
| Display label | with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin |
| Total patents | 27 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH
US-12351597-B2 · Jul 8, 2025 · US
Amphiphilic kanamycin compositions and methods
US-12110310-B2 · Oct 8, 2024 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-11865128-B2 · Jan 9, 2024 · US
E-selectin targeting agents
US-2023364277-A1 · Nov 16, 2023 · US
Chromatographic material having improved pH stability, method for preparation thereof and uses thereof
US-11813588-B2 · Nov 14, 2023 · US
Neomycin and paromomycin derivatives
US-11466044-B2 · Oct 11, 2022 · US
Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of fimh
US-2022242900-A1 · Aug 4, 2022 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-2021228608-A1 · Jul 29, 2021 · US
Amphiphilic Kanamycin Compositions and Methods
US-2021230203-A1 · Jul 29, 2021 · US
Chromatographic material having improved ph stability, method for preparation thereof and uses thereof
US-2021213420-A1 · Jul 15, 2021 · US
Neomycin and paromomycin derivatives
US-2021107932-A1 · Apr 15, 2021 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-10973839-B2 · Apr 13, 2021 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-2020078386-A1 · Mar 12, 2020 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-10398718-B2 · Sep 3, 2019 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-2019224226-A9 · Jul 25, 2019 · US
Aminoglycoside derivatives and uses thereof in treating microbial infections
US-2019016745-A1 · Jan 17, 2019 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-2018200276-A1 · Jul 19, 2018 · US
Aminoglycosides and uses thereof in treating genetic disorders
US-9943533-B2 · Apr 17, 2018 · US
Chromatographic material having improved ph stability, method for preparation thereof and uses thereof
US-2018008959-A1 · Jan 11, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07H15/23?
- CPC C07H15/23 is the Cooperative Patent Classification code for “with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin.”
- How many patents are filed under CPC C07H15/23 (with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin)?
- Our database includes 27 publications tagged with this CPC code.
- Is patent activity under CPC C07H15/23 growing?
- Publication counts under this code: 2 in 2024 vs 1 in 2025 (latest complete years).